Shingles - References

References

Citations

1. Whitley RJ (2005). Varicella-zoster virus. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed., vol. 2, pp. 1780–1786. Philadelphia: Elsevier/Churchill Livingstone.

   Related Articles

   • Shingles - Treatment Overview
   • Shingles - Topic Overview

   » More resources Articles

2. Suzuki K, et al. (2004). Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. Journal of Infectious Diseases, 189(6): 1009–1012.

3. Barnes SD, et al. (2005). Microbial keratitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed., vol. 1, pp. 1395–1406. Philadelphia: Elsevier/Churchill Livingstone.

4. Gnann JW, Whitley RJ (2002). Herpes zoster. New England Journal of Medicine, 347(5): 340–346.

5. Ashkenazi A, Levin M (2004). Three common neuralgias: How to manage trigeminal, occipital, and postherpetic pain. Postgraduate Medicine, 116(3): 16–48.

6. Dubinsky RM, et al. (2004). Practice parameter: Treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 63(6): 959–965.

7. Jung BF, et al. (2004). Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology, 62(9): 1545–1551.

8. Gilden DH, et al. (2000). Neurologic complications of the reactivation of varicella-zoster virus. New England Journal of Medicine, 342(9): 635–645.

Other Works Consulted

• Gilden DH (2006). Acute viral central nervous system diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 16. New York: WebMD.

• Herpes zoster vaccine (Zostavax) (2006). Medical Letter on Drugs and Therapeutics, 48(1243): 73–74.

• Johnson RW, Dworkin RH (2003). Treatment of herpes zoster and postherpetic neuralgia. BMJ, 326(7392): 748–750.

• Katz J, et al. (2004). Acute pain in herpes zoster and its impact on health-related quality of life. Clinical Infectious Diseases, 39(3): 342–348.

• Pregabalin (Lyrica) for neuropathic pain and epilepsy (2005). Medical Letter on Drugs and Therapeutics, 47(1217): 75–76.